BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24402195)

  • 1. Transforming growth factor (TGF)-β levels and unprovoked recurrent venous thromboembolism.
    Memon AA; Sundquist K; Wang X; Svensson PJ; Sundquist J; Zöller B
    J Thromb Thrombolysis; 2014 Oct; 38(3):348-54. PubMed ID: 24402195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of recurrent venous thromboembolism and circulating microRNAs.
    Wang X; Sundquist K; Svensson PJ; Rastkhani H; Palmér K; Memon AA; Sundquist J; Zöller B
    Clin Epigenetics; 2019 Feb; 11(1):28. PubMed ID: 30760335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein M and the risk of unprovoked recurrent venous thromboembolism.
    Memon AA; Sundquist J; Zöller B; Wang X; Dahlbäck B; Svensson PJ; Sundquist K
    Thromb Res; 2014 Mar; 133(3):322-6. PubMed ID: 24359967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of family history of venous thromboembolism and thrombophilia as predictors of recurrence: a prospective follow-up study.
    Sundquist K; Sundquist J; Svensson PJ; Zöller B; Memon AA
    J Thromb Haemost; 2015 Dec; 13(12):2180-6. PubMed ID: 26407905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
    Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
    Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study.
    Rokx C; Borjas Howard JF; Smit C; Wit FW; Pieterman ED; Reiss P; Cannegieter SC; Lijfering WM; Meijer K; Bierman W; Tichelaar V; Rijnders BJA;
    PLoS Med; 2020 May; 17(5):e1003101. PubMed ID: 32407386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fat mass and obesity-associated gene rs9939609 polymorphism is a potential biomarker of recurrent venous thromboembolism in male but not in female patients.
    Ahmad A; Memon AA; Sundquist J; Svensson PJ; Zöller B; Sundquist K
    Gene; 2018 Mar; 647():136-142. PubMed ID: 29325734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.
    Khan F; Rahman A; Carrier M; Kearon C; Weitz JI; Schulman S; Couturaud F; Eichinger S; Kyrle PA; Becattini C; Agnelli G; Brighton TA; Lensing AWA; Prins MH; Sabri E; Hutton B; Pinede L; Cushman M; Palareti G; Wells GA; Prandoni P; Büller HR; Rodger MA;
    BMJ; 2019 Jul; 366():l4363. PubMed ID: 31340984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between TLR9 rs5743836 polymorphism and risk of recurrent venous thromboembolism.
    Ahmad A; Sundquist K; Zöller B; Svensson PJ; Sundquist J; Memon AA
    J Thromb Thrombolysis; 2017 Jul; 44(1):130-138. PubMed ID: 28321710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High rate of recurrent venous thromboembolism in children and adolescents with unprovoked venous thromboembolism.
    Whitworth H; Clark HH; Hubbard RA; Witmer C; Leonard CE; Raffini L
    J Thromb Haemost; 2023 Jan; 21(1):47-56. PubMed ID: 36695395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk prediction of recurrent venous thromboembolism: a multiple genetic risk model.
    Ahmad A; Sundquist K; Palmér K; Svensson PJ; Sundquist J; Memon AA
    J Thromb Thrombolysis; 2019 Feb; 47(2):216-226. PubMed ID: 30368761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombophilia and risk of VTE recurrence according to the age at the time of first VTE manifestation.
    Weingarz L; Schindewolf M; Schwonberg J; Hecking C; Wolf Z; Erbe M; Lindhoff-Last E; Linnemann B
    Vasa; 2015 Jul; 44(4):313-23. PubMed ID: 26314364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.
    Palareti G; Legnani C; Cosmi B; Valdré L; Lunghi B; Bernardi F; Coccheri S
    Circulation; 2003 Jul; 108(3):313-8. PubMed ID: 12847064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombomodulin gene c.1418C>T polymorphism and risk of recurrent venous thromboembolism.
    Ahmad A; Sundquist K; Zöller B; Svensson PJ; Sundquist J; Memon AA
    J Thromb Thrombolysis; 2016 Jul; 42(1):135-41. PubMed ID: 26743062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-OO blood type influences the risk of recurrent venous thromboembolism. A cohort study.
    Gándara E; Kovacs MJ; Kahn SR; Wells PS; Anderson DA; Chagnon I; Le Gal G; Solymoss S; Crowther M; Carrier M; Langlois N; Kovacs J; Little Ma J; Carson N; Ramsay T; Rodger MA
    Thromb Haemost; 2013 Dec; 110(6):1172-9. PubMed ID: 24067945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of hereditary thrombophilia testing among patients with unprovoked venous thromboembolism.
    Olivo Freites C; Naymagon L
    Int J Lab Hematol; 2022 Apr; 44(2):393-398. PubMed ID: 34749438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism.
    White RH; Chan WS; Zhou H; Ginsberg JS
    Thromb Haemost; 2008 Aug; 100(2):246-52. PubMed ID: 18690344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Genetic Aberrations in Thrombomodulin Gene in Patients With Recurrent Venous Thromboembolism.
    Ahmad A; Sundquist K; Zöller B; Svensson PJ; Sundquist J; Memon AA
    Clin Appl Thromb Hemost; 2017 May; 23(4):319-328. PubMed ID: 28049360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of polymorphisms in Apolipoprotein M gene and their relationship with risk of recurrent venous thromboembolism.
    Ahmad A; Sundquist K; Zöller B; Dahlbäck B; Svensson PJ; Sundquist J; Memon AA
    Thromb Haemost; 2016 Aug; 116(3):432-41. PubMed ID: 27277397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of in situ and plasma levels of transforming growth factor β1, -2 and -3 in cutaneous melanoma.
    Tang MR; Wang YX; Guo S; Han SY; Li HH; Jin SF
    Mol Med Rep; 2015 Jun; 11(6):4508-12. PubMed ID: 25625662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.